Selected research
Industry Research
Veterinary Dermatology Drugs Industry Research Report 2026
Market perspective
The global Veterinary Dermatology Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Veterinary Dermatology Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Veterinary Dermatology Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Veterinary Dermatology Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Veterinary Dermatology Drugs include Com Zoetis Inc., Bayer Animal Health, Virbac S.A., Vetoquinol S.A.panies, Merial, IDEXX Laboratories, Elanco, Ceva Sante Animale and Boehringer Ingelheim Vetmedica, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Veterinary Dermatology Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Dermatology Drugs Market by Company
Com Zoetis Inc.
Bayer Animal Health
Virbac S.A.
Vetoquinol S.A.panies
Merial
IDEXX Laboratories
Elanco
Ceva Sante Animale
Boehringer Ingelheim Vetmedica
Veterinary Dermatology Drugs Segment by Type
NSAIDS
Antibiotics
Veterinary Antifungal Drugs
Others
Veterinary Dermatology Drugs Segment by Application
Veterinary Clinics
Veterinary Hospitals
Others
Veterinary Dermatology Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Dermatology Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Dermatology Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Dermatology Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Dermatology Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Dermatology Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Dermatology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- NSAIDS
- Antibiotics
- Veterinary Antifungal Drugs
- Others
Applications
- Veterinary Clinics
- Veterinary Hospitals
- Others
Companies covered
- Com Zoetis Inc.
- Bayer Animal Health
- Virbac S.A.
- Vetoquinol S.A.panies
- Merial
- IDEXX Laboratories
- Elanco
- Ceva Sante Animale
- Boehringer Ingelheim Vetmedica
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Veterinary Dermatology Drugs Market Size (2021-2032)
- 2.2.2 Global Veterinary Dermatology Drugs Sales (2021-2032)
- 2.2.3 Global Veterinary Dermatology Drugs Market Average Price (2021-2032)
- 2.3 Veterinary Dermatology Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 NSAIDS
- 2.3.3 Antibiotics
- 2.3.4 Veterinary Antifungal Drugs
- 2.3.5 Others
- 2.4 Veterinary Dermatology Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Veterinary Clinics
- 2.4.3 Veterinary Hospitals
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Veterinary Dermatology Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Veterinary Dermatology Drugs Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Veterinary Dermatology Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Veterinary Dermatology Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Veterinary Dermatology Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Veterinary Dermatology Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Veterinary Dermatology Drugs, Product Type & Application
- 3.8 Global Manufacturers of Veterinary Dermatology Drugs, Established Date
- 3.9 Global Veterinary Dermatology Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Com Zoetis Inc.
- 4.1.1 Com Zoetis Inc. Company Information
- 4.1.2 Com Zoetis Inc. Business Overview
- 4.1.3 Com Zoetis Inc. Veterinary Dermatology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Com Zoetis Inc. Veterinary Dermatology Drugs Product Portfolio
- 4.1.5 Com Zoetis Inc. Recent Developments
- 4.2 Bayer Animal Health
- 4.2.1 Bayer Animal Health Company Information
- 4.2.2 Bayer Animal Health Business Overview
- 4.2.3 Bayer Animal Health Veterinary Dermatology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bayer Animal Health Veterinary Dermatology Drugs Product Portfolio
- 4.2.5 Bayer Animal Health Recent Developments
- 4.3 Virbac S.A.
- 4.3.1 Virbac S.A. Company Information
- 4.3.2 Virbac S.A. Business Overview
- 4.3.3 Virbac S.A. Veterinary Dermatology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Virbac S.A. Veterinary Dermatology Drugs Product Portfolio
- 4.3.5 Virbac S.A. Recent Developments
- 4.4 Vetoquinol S.A.panies
- 4.4.1 Vetoquinol S.A.panies Company Information
- 4.4.2 Vetoquinol S.A.panies Business Overview
- 4.4.3 Vetoquinol S.A.panies Veterinary Dermatology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Vetoquinol S.A.panies Veterinary Dermatology Drugs Product Portfolio
- 4.4.5 Vetoquinol S.A.panies Recent Developments
- 4.5 Merial
- 4.5.1 Merial Company Information
- 4.5.2 Merial Business Overview
- 4.5.3 Merial Veterinary Dermatology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merial Veterinary Dermatology Drugs Product Portfolio
- 4.5.5 Merial Recent Developments
- 4.6 IDEXX Laboratories
- 4.6.1 IDEXX Laboratories Company Information
- 4.6.2 IDEXX Laboratories Business Overview
- 4.6.3 IDEXX Laboratories Veterinary Dermatology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 IDEXX Laboratories Veterinary Dermatology Drugs Product Portfolio
- 4.6.5 IDEXX Laboratories Recent Developments
- 4.7 Elanco
- 4.7.1 Elanco Company Information
- 4.7.2 Elanco Business Overview
- 4.7.3 Elanco Veterinary Dermatology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Elanco Veterinary Dermatology Drugs Product Portfolio
- 4.7.5 Elanco Recent Developments
- 4.8 Ceva Sante Animale
- 4.8.1 Ceva Sante Animale Company Information
- 4.8.2 Ceva Sante Animale Business Overview
- 4.8.3 Ceva Sante Animale Veterinary Dermatology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ceva Sante Animale Veterinary Dermatology Drugs Product Portfolio
- 4.8.5 Ceva Sante Animale Recent Developments
- 4.9 Boehringer Ingelheim Vetmedica
- 4.9.1 Boehringer Ingelheim Vetmedica Company Information
- 4.9.2 Boehringer Ingelheim Vetmedica Business Overview
- 4.9.3 Boehringer Ingelheim Vetmedica Veterinary Dermatology Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Boehringer Ingelheim Vetmedica Veterinary Dermatology Drugs Product Portfolio
- 4.9.5 Boehringer Ingelheim Vetmedica Recent Developments
5 Global Veterinary Dermatology Drugs Market Scenario by Region
- 5.1 Global Veterinary Dermatology Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Veterinary Dermatology Drugs Sales by Region: 2021-2032
- 5.2.1 Global Veterinary Dermatology Drugs Sales by Region: 2021-2026
- 5.2.2 Global Veterinary Dermatology Drugs Sales by Region: 2027-2032
- 5.3 Global Veterinary Dermatology Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Veterinary Dermatology Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Veterinary Dermatology Drugs Revenue by Region: 2027-2032
- 5.4 North America Veterinary Dermatology Drugs Market Facts & Figures by Country
- 5.4.1 North America Veterinary Dermatology Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Veterinary Dermatology Drugs Sales by Country (2021-2032)
- 5.4.3 North America Veterinary Dermatology Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Veterinary Dermatology Drugs Market Facts & Figures by Country
- 5.5.1 Europe Veterinary Dermatology Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Veterinary Dermatology Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Veterinary Dermatology Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Veterinary Dermatology Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Veterinary Dermatology Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Veterinary Dermatology Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Veterinary Dermatology Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Veterinary Dermatology Drugs Market Facts & Figures by Country
- 5.7.1 South America Veterinary Dermatology Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Veterinary Dermatology Drugs Sales by Country (2021-2032)
- 5.7.3 South America Veterinary Dermatology Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Veterinary Dermatology Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Veterinary Dermatology Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Veterinary Dermatology Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Veterinary Dermatology Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Veterinary Dermatology Drugs Sales by Type (2021-2032)
- 6.1.1 Global Veterinary Dermatology Drugs Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Veterinary Dermatology Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Veterinary Dermatology Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Veterinary Dermatology Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Veterinary Dermatology Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Veterinary Dermatology Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Veterinary Dermatology Drugs Sales by Application (2021-2032)
- 7.1.1 Global Veterinary Dermatology Drugs Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Veterinary Dermatology Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Veterinary Dermatology Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Veterinary Dermatology Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Veterinary Dermatology Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Veterinary Dermatology Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Veterinary Dermatology Drugs Value Chain Analysis
- 8.1.1 Veterinary Dermatology Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Veterinary Dermatology Drugs Production Mode & Process
- 8.2 Veterinary Dermatology Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Veterinary Dermatology Drugs Distributors
- 8.2.3 Veterinary Dermatology Drugs Customers
9 Global Veterinary Dermatology Drugs Analyzing Market Dynamics
- 9.1 Veterinary Dermatology Drugs Industry Trends
- 9.2 Veterinary Dermatology Drugs Industry Drivers
- 9.3 Veterinary Dermatology Drugs Industry Opportunities and Challenges
- 9.4 Veterinary Dermatology Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst